Billions of dollars and an immeasurable level of excitement surround precision medicine, but several researchers say the real-world challenges tied to these initiatives should temper expectations.
The promise of precision medicine has been widely embraced by the medical community, particularly after President Barack Obama unveiled the Precision Medicine Initiative in 2015, and then doubled down with the Cancer Moonshot initiative. The recently enacted 21st Century Cures Act includes significant funding for both programs, although some say the Cancer Moonshot program may be at risk under President Trump.
